Study of the Analgesic Efficacy and Safety of Subcutaneous Tanezumab in Subjects With Osteoarthritis of the Hip or Knee.
Clinical trial NCT02709486 · COMPLETED
Trial details
- NCT number
- NCT02709486
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-02
- Primary completion
- 2018-06-08
- Enrollment
- 849
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.